CytomX Therapeutics, Inc. (CTMX)
5.00
+0.19
(+3.95%)
USD |
NASDAQ |
Mar 04, 10:33
CytomX Therapeutics Research and Development Expense (Annual) : 81.76M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| REGENXBIO, Inc. | 192.31M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 78.03M |
| BioMarin Pharmaceutical, Inc. | 700.97M |